Questions? 800.667.7745; Voice Mail: 925-391-0363
Email: [email protected]
Add To Cart

Section 9
Advance care planning: preferences for care at the end of life

Answer Booklet | Table of Contents | Printable Page

The Publication below is from Agency for Healthcare Research and Quality. 

Hint:
1. Use + and – at top of page to increase or decrease size
2. Click and drag on page to move text to be more visible , if needed
3. Click speaker at top of page to add or delete sound
4. If message below indicates "A plugin is needed to display this content." CLICK HERE
Questions? Email: [email protected]

- Kass-Bartelmes BL, Hughes R, Rutherford MK. Advance care planning: preferences for care at the end of life. Rockville (MD): Agency for Healthcare Research and Quality; 2003. Research in Action Issue #12. AHRQ Pub No. 03-0018, p1-20.
The article above contains foundational information. Articles below contain optional updates.


Answer Booklet for this course
Forward to Section 10
Back to Section 8
Table of Contents
Top


The article above contains foundational information. Articles below contain optional updates.
More Articles on 50+ topics
How bacteria in the gut influence neurodegenerative disorders - November 16, 2017
Humans have roughly as many bacterial cells in their bodies as human cells, and most of those bacteria live in the gut. New research released today reveals links between the gut microbiome -- the population of microorganisms living in the gastrointestinal tract -- and brain diseases such as Parkinson's and Alzheimer's, including potential new ways to track and treat these diseases.
Uninsured heart attack, stroke patients face ‘catastrophic’ costs - November 16, 2017
Heart attack and stroke patients without medical insurance face “devastating” health care costs that can bankrupt them, research shows.
Virtual reality training may be as effective as regular therapy after stroke - November 15, 2017
Using virtual reality therapy to improve arm and hand movement after a stroke is equally as effective as regular therapy, according to a study.
U.S. health care system unprepared to move future Alzheimer's treatment into rapid clinical use - November 15, 2017
Advanced clinical trials are underway for at least 10 investigational therapies that have shown promise in slowing or blocking development of Alzheimer's disease, creating hope that a preventive strategy may be in reach. But a new study warns that the U.S. health care system lacks the capacity to rapidly move such a treatment into wide clinical use, a shortcoming that could leave millions of people without access to transformative care if such a breakthrough occurs.
Improving clinical trials with machine learning - November 15, 2017
Machine learning could improve our ability to determine whether a new drug works in the brain, potentially enabling researchers to detect drug effects that would be missed entirely by conventional statistical tests, finds a new study.